Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2021 02:00 ET | Source: Immunicum AB

Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften Cells

Pressmeddelande22 november 2021 Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften CellsImmunicum AB (publ; IMMU.ST), ett biofarmaceutiskt företag fokuserat på svårbehandlade solida...
November 22, 2021 02:00 ET | Source: Immunicum AB

Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells

Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat...
November 09, 2021 08:00 ET | Source: Immunicum AB

Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)

PressmeddelandeStockholm, Sverige, 9 november 2021Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)Immunicum AB (publ; IMMU.ST), ett bioteknikföretag...
November 09, 2021 08:00 ET | Source: Immunicum AB

Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting

Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual MeetingImmunicum AB (publ; IMMU.ST), a biopharmaceutical...
November 04, 2021 09:02 ET | Source: Immunicum AB

Immunicum presenterar uppdaterade resultat för Fas II ADVANCE II vid Annual American Society of Hematology Meeting (ASH)

Pressmeddelande 4 november 2021 Immunicum presenterar uppdaterade resultat för Fas II ADVANCE II vid Annual American Society of Hematology Meeting (ASH) Immunicum AB (publ; IMMU.ST), ett...
November 04, 2021 09:02 ET | Source: Immunicum AB

Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH)

Press Release November 4, 2021 Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH) Immunicum AB (publ; IMMU.ST), a biopharmaceutical...
November 03, 2021 03:00 ET | Source: Immunicum AB

Immunicum tillkännager valberedning inför årsstämman 2022

Pressmeddelande 03 november 2021 Immunicum tillkännager valberedning inför årsstämman 2022 Immunicum AB (publ: IMMU.ST) meddelade idag att ledamöterna i valberedningen har utsetts i enlighet...
November 03, 2021 03:00 ET | Source: Immunicum AB

Immunicum Announces Nomination Committee for the 2022 Annual General Meeting

Press Release November 3, 2021 Immunicum Announces Nomination Committee for the 2022 Annual General Meeting Immunicum AB (publ: IMMU.ST) announced today that the members of the Nomination...
November 01, 2021 03:00 ET | Source: Immunicum AB

Immunicum deltar i ett flertal industri – och investerarkonferenser under november månad

Pressmeddelande 1 november 2021 Immunicum deltar i ett flertal industri – och investerarkonferenser under november månad Immunicum AB (publ) meddelade idag att bolaget kommer att delta i,...
November 01, 2021 03:00 ET | Source: Immunicum AB

Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November

Press Release 01 November 2021 Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November Immunicum AB (publ) today announced that it will participate and...